๐๏ธ Verified NIH Record โข Updated 2024-11-15
Spinraza in Adult Spinal Muscular Atrophy (NCT03709784)
A Prospective, Multi-center, Observational Study of the Safety, Tolerability and Effectiveness of SPINRAZAยฎ (Nusinersen) in Adult Patients With Spinal Muscular Atrophy
๐ต Active, Not Recruiting Interventional Protocol ๐ Observational Clinical Research Sponsor: Washington University School of Medicine
๐ฉบ Plain-English Summary (8th-Grade Level)
This is a longitudinal, observational study of adult patients with genetically confirmed chromosome 5q SMA to examine the safety, tolerability, and effectiveness of SPINRAZAยฎ (nusinersen) for up to 30 months.
Who can join: Review the eligibility criteria below.
Location: Barrow Neurological Institute โ Phoenix, Arizona
Age range: 18 Years to 70 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (11 Sites)
- Barrow Neurological Institute โ Phoenix, Arizona
- Georgetown University โ Washington D.C., District of Columbia
- Johns Hopkins โ Baltimore, Maryland
- Massachusetts General Hospital-Harvard University โ Boston, Massachusetts
- Memorial Healthcare โ Owosso, Michigan
- Washington University School of Medicine โ St Louis, Missouri
- New York University School of Medicine โ New York, New York
- Houston Methodist Neurological Institute โ Houston, Texas
- Children's Hospital of the King's Daughthers โ Norfolk, Virginia
- University of Washington โ Seattle, Washington
- Montreal Neurological Institute and Hospital โ Montreal, Quebec
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Spinal Muscular Atrophy
- Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA) โ Phoenix, Arizona
- Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb โ Pittsburgh, Pennsylvania
- A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Risdiplam (ASCEND) โ Phoenix, Arizona
- Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab โ Phoenix, Arizona
- Early Check: Expanded Screening in Newborns โ Research Triangle Park, North Carolina
Explore by condition: All Spinal Muscular Atrophy clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.